NCT03269955View on ClinicalTrials.gov

The Effect of Application of TachoSil® in Pancreatoduodenectomy

PHASE4UnknownINTERVENTIONAL
Enrollment

126

Participants

Timeline

Start Date

February 27, 2017

Primary Completion Date

May 31, 2018

Study Completion Date

May 31, 2018

Conditions
Pancreatic NeoplasmPancreatic Periampullary CancerPancreatic Bordeline Tumor
Interventions
DRUG

Fibrinogen/thrombin-coated collagen patch

Tachosil® is cut in half and applied to the front and back of the pancreaticojejunostomy respectively, and fibrin glue is applied on it

Trial Locations (1)

05505

RECRUITING

Asan Medical Center, Seoul

Sponsors
All Listed Sponsors
lead

Asan Medical Center

OTHER

NCT03269955 - The Effect of Application of TachoSil® in Pancreatoduodenectomy | Biotech Hunter | Biotech Hunter